Skip to main content
Log in

Visceral obesity is associated with an increased risk of developing esophago-gastric junctional adenocarcinoma in Japan: a population-based case–control study in Akita Prefecture

  • Original Article
  • Published:
Esophagus Aims and scope Submit manuscript

Abstract

Background

While an association between esophago-gastric junctional adenocarcinomas (EGJACs) and obesity, especially visceral obesity, has been suggested in Western countries, the association remains unclear in Asia, including Japan. In this population-based case–control study, we investigated the association between EGJACs and obesity.

Methods

To perform near-population-based data collection for all early-stage EGJACs occurring in Akita Prefecture from 2014 to 2019, clinical data, including endoscopic and computed tomography (CT) findings, were collected from 11 cancer treatment base hospitals in the area. Age- and gender-matched controls were extracted at a case-to-control ratio of 1:2 from healthy subjects who received health checkups in the same area. The visceral fat area (VFA) was calculated using CT images. Logistic regression analyses were performed to investigate the associations between EGJACs and obesity-related parameters.

Results

In total, 74 EGJAC cases (62 males, median age of 70 years old) and 148 controls were extracted. Multivariable analyses showed a significantly negative association between the BMI and EGJACs and a significantly positive association between the VFA and EGJACs with odds ratios (ORs) (95% confidence intervals [CIs]) of 0.65 (0.53–0.80) and 1.01 (1.01–1.02), respectively. These findings were confirmed in another dataset (40 EGJACs and 80 controls). In addition, as a categorical variable, VFA ≥ 100 cm2 showed a significantly positive association with EGJACs (OR [95% CI] 1.96 [1.02–3.76]).

Conclusions

We found paradoxical associations between EGJACs and obesity-related parameters (BMI vs. VFA) in a Japanese population, suggesting a potentially pivotal role of the VFA rather than the BMI as a risk factor for EGJACs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Melina A, Isabelle S, Jacques F, et al. Global incidence of oesophageal cancer by histological subtype in 2012. Gut. 2015;64:381–7.

    Article  Google Scholar 

  2. Thrift AP, Whiteman DC. The incidence of esophageal adenocarcinoma continues to rise: analysis of period and birth cohort effects on recent trends. Ann Oncol. 2012;23:3155–62.

    Article  CAS  Google Scholar 

  3. Kubo A, Corley DA. Body mass index and adenocarcinomas of the esophagus or gastric cardia: a systematic review and meta-analysis. Cancer Epidemiol Biomark Prev. 2006;15:872–8.

    Article  Google Scholar 

  4. Kvist H, Chowdhury B, Sjostrom L, et al. Adipose tissue colume determination in males by computed tomography and 40 K. Int J Obes. 1988;12:239–66.

    Google Scholar 

  5. Bulcão C, Ferreira SR, Giuffrida FM, et al. The new adipose tissue and adipocytokines. Curr Diabetes Rev. 2006;2:19–28.

    Article  Google Scholar 

  6. El-Serag HB, Kvapil P, Hacken-Bitar J, et al. Abdominal obesity and the risk of Barrett’s esophagus. Am J Gastroenterol. 2005;100:2151–6.

    Article  Google Scholar 

  7. El-Serag HB, Hashmi A, Garcia J, et al. Visceral abdominal obesity measured by CT scan is associated with an increased risk of Barrett’s oesophagus: a case–control study. Gut. 2014;63:220–9.

    PubMed  Google Scholar 

  8. Massl R, van Blankenstein M, Hermans JJ, et al. Visceral adipose tissue: the link with esophageal adenocarcinoma. Scand J Gastroenterol. 2014;49:449–57.

    Article  Google Scholar 

  9. Beddy P, Howard J, McMahon C, et al. Association of visceral adiposity with oesophageal and junctional adenocarcinomas. Br J Surg. 2010;97:1028–34.

    Article  CAS  Google Scholar 

  10. Koizumi S, Motoyama S, Iijima K. Is the incidence of esophageal adenocarcinoma increasing in Japan? Trends from the data of a hospital-based registration system in Akita Prefecture. Japan J Gastroenterol. 2018;53:827–33.

    Article  Google Scholar 

  11. Nishi T, Makuuchi H, Ozawa S, et al. The present status and future of Barrett’s esophageal adenocarcinoma in Japan. Digestion. 2019;99:185–90.

    Article  Google Scholar 

  12. Matsuno K, Ishihara R, Ohmori M, et al. Time trends in the incidence of esophageal adenocarcinoma, gastric adenocarcinoma, and superficial esophagogastric junction adenocarcinoma. J Gastroenterol. 2019;54:784–91.

    Article  CAS  Google Scholar 

  13. Matsueda K, Manabe N, Toshikuni N, et al. Clinical characteristics and associated factors of Japanese patients with adenocarcinoma of the esophagogastric junction: a multicenter clinicoepidemiological study. Dis Esophagus. 2017;30:1–6.

    Article  CAS  Google Scholar 

  14. Zhang J, Su XQ, Wu XJ, et al. Effect of body mass index on adenocarcinoma of gastric cardia. World J Gastroenterol. 2003;9:2658–61.

    Article  Google Scholar 

  15. Usui G, Shinozaki T, Jinno T, et al. Association between visceral abdominal obesity and long-segment Barrett’s esophagus in a Japanese population. J Gastroenterol. 2020;55:189–97.

    Article  CAS  Google Scholar 

  16. Koizumi S, Motoyama S, Watanabe N, et al. Chronological changes in the gastric cancer subsite in Akita, Japan: the trends from the data of a hospital-based registration system. Tohoku J Exp Med. 2018;246:131–40.

    Article  Google Scholar 

  17. Siewert JR, Stein HJ. Classification of carcinoma of the oeso-phagogastric junction. Br J Surg. 1998;85:1457–9.

    Article  CAS  Google Scholar 

  18. Takubo K, Vieth M, Aida J, et al. Histopathological diagnosis of adenocarcinoma in Barrett’s esophagus. Dig Endosc. 2014;26:322–30.

    Article  Google Scholar 

  19. Japan Esophageal Society. Japanese classification of esophageal cancer, 11th edition: part I. Esophagus. 2017;14:1–36.

    Article  Google Scholar 

  20. Tokunaga K, Matsuzawa Y, Ishikawa K, et al. A novel technique for the determination of body fat by computed tomography. Int J Obes. 1983;7:437–45.

    CAS  PubMed  Google Scholar 

  21. Fukuda S, Watanabe K, Yoshida T, et al. Low risk of esophageal adenocarcinoma among patients with ultrashort-segment Barrett’s esophagus in Japan. Dig Endosc. 2021. https://doi.org/10.1111/den.14118.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Examination Committee of Criteria for ‘Obesity Disease’ in Japan; Japan Society for the Study of Obesity New criteria for ‘obesity disease’ in Japan. Cir J 2002;66:987–92.

  23. Hiuge-Shimizu A, Kishida K, Funahashi T, et al. Absolute value of visceral fat area measured on computed tomography scans and obesity-related cardiovascular risk factors in large-scale Japanese general population (the VACATION-J study). Ann Med. 2012;44:82–92.

    Article  Google Scholar 

  24. Kanda Y. Investigation of the freely available easy-to-use software “EZR” for medical statistics. Bone Marrow Transplant. 2013;48:452–8.

    Article  CAS  Google Scholar 

  25. Lagergren J, Bergstrom R, Nyren O. Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann Intern Med. 1999;130:883–90.

    Article  CAS  Google Scholar 

  26. Anderson LA, Watson RG, Murphy SJ, et al. Risk factors for Barrett’s oesophagus and oesophageal adenocarcinoma: results from the FINBAR study. World J Gastroenterol. 2007;13:1585–94.

    Article  Google Scholar 

  27. Dalamaga M, Diakopoulos KN, Mantzoros CS. The role of adiponectin in cancer: a review of current evidence. Endocr Rev. 2012;33:547–94.

    Article  CAS  Google Scholar 

  28. Vucenik I, Stains JP. Obesity and cancer risk: evidence, mechanisms, and recommendations. Ann N Y Acid Sci. 2012;1271:37–43.

    Article  CAS  Google Scholar 

  29. Nam SY, Choi IJ, Ryu KH, et al. Abdominal visceral adipose tissue volume is associated with increased risk of erosive esophagitis in men and women. Gastroenterology. 2010;139:1902–11.

    Article  Google Scholar 

  30. Pandolfino JE, El-Serag HB, Zhang Q, et al. Obesity: a challenge to esophagogastric junction integrity. Gastroenterology. 2006;130:639–49.

    Article  Google Scholar 

  31. Fontana L, Eagon JC, Trujillo ME, et al. Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. Diabetes. 2007;56:1010–3.

    Article  CAS  Google Scholar 

  32. Kim YM, Kim JH, Baik SJ, et al. Sarcopenia and sarcopenic obesity as novel risk factors for gastric carcinogenesis: a health checkup cohort study. Front Oncol. 2019;9:1249.

    Article  Google Scholar 

  33. Wannamethee SG, Atkins JL. Muscle loss and obesity: the health implications of sarcopenia and sarcopenic obesity. Proc Nutr Soc. 2015;74:405–12.

    Article  Google Scholar 

  34. Ciudin A, Simo-Servat A, Palmas F, et al. Sarcopenic obesity: a new challenge in the clinical practice. Endocrinol Diabetes Nutr (Engl Ed). 2020;67:672–81.

    Google Scholar 

  35. The National Health and Nutrition Survey in Japan, 2016. The Ministry of Health, Labor and Welfare. 2016. https://www.nibiohn.go.jp/eiken/kenkounippon21/en/eiyouchousa/.

  36. Hansen S, Vollset SE, Derakhshan MH, et al. Two distinct aetiologies of cardia cancer; evidence from premorbid serological markers of gastric atrophy and Helicobacter pylori status. Gut. 2007;56:918–25.

    Article  CAS  Google Scholar 

  37. Horii T, Koike T, Abe Y, et al. Two distinct types of cancer of different origin may be mixed in gastroesophageal junction adenocarcinomas in Japan: evidence from direct evaluation of gastric acid secretion. Scand J Gastroenterol. 2011;46:710–9.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kenta Watanabe.

Ethics declarations

Ethical statement

This study was approved by the Ethics Committee of Akita University Graduate School of Medicine (2294) and other cooperating institutions.

Conflict of interest

The authors declare that they have no conflict of interest associated with this manuscript.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 33 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Watanabe, K., Koizumi, S., Shirane, K. et al. Visceral obesity is associated with an increased risk of developing esophago-gastric junctional adenocarcinoma in Japan: a population-based case–control study in Akita Prefecture. Esophagus 19, 477–485 (2022). https://doi.org/10.1007/s10388-021-00906-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10388-021-00906-1

Keywords

Navigation